Rheumatoid arthritis is a crippling autoimmune inflammatory chronic disease that causes pain, swelling and joint stiffness, with limited movement and function of the joints, since the main target of inflammation is the synovial membrane of the joints. In many cases the first symptoms appear gradually, and consist of morning stiffness in the movements of the hands, or in any case of the joints involved, which improves during the day. In addition, the patient can also report symptoms known as “extra-articular”, which may be indicative of systemic involvement of the disease. Of unknown etiology, it is a disease that mainly affects women. The pharmacological treatment aims to prevent the worsening of the synovial damage and the consequent disability condition of the patient.
Through this genetic test it will be possible to have indications on which of these drugs is most suitable for your body.